Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine

被引:465
作者
Hansen, L
Deacon, CF
Orskov, C
Holst, JJ
机构
[1] Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen N, Denmark
[2] Univ Copenhagen, Panum Inst, Dept Med Anat, DK-2200 Copenhagen N, Denmark
关键词
D O I
10.1210/en.140.11.5356
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The insulinotropic hormone glucagon-like peptide-1 (GLP-1) is stored in the intestinal L cell in an active form, GLP-1-(7-36)amide, but more than half of the endogenous peptide circulates in an inactive, N-terminally truncated form, GLP-1-(9-36)amide. This study examined the GLP-1 newly secreted from the porcine ileum, in vitro (isolated perfused preparation) and in vivo (anesthetized pig), to determine where this conversion occurs. Although the GLP-1 extractable from the porcine ileum is predominantly the intact peptide (94.6 +/- 1.7%), a large proportion of the GLP-1 that is secreted has already been degraded to the truncated form both in, vitro (53.8 +/-: 0.9% intact) and in, vivo (32.9 +/- 10.8% intact). In the presence of a specific dipeptidyl peptidase TV (DPP TV) inhibitor (valine-pyrrolidide), the proportion of intact GLP-1 released from the perfused ileum was increased under both basal(99% intact; P < 0.05) and stimulated (86-101% intact; P < 0.05) conditions. Immunohistochemical and histochemical studies revealed specific DPP TV staining in the brush border epithelium as well as in the capillary endothelium. Double staining showed juxtapositioning of DPP IV-positive capillaries and GLP-1-containing L cells. From these results, we suggest that GLP-1 is degraded as it enters the DPP IV containing blood vessels draining the intestinal mucosa.
引用
收藏
页码:5356 / 5363
页数:8
相关论文
共 44 条
[1]   THE INTESTINAL-MUCOSA PREFERENTIALLY RELEASES SOMATOSTATIN-28 IN PIGS [J].
BALDISSERA, FGA ;
NIELSEN, OV ;
HOLST, JJ .
REGULATORY PEPTIDES, 1985, 11 (03) :251-262
[2]  
Balkan B, 1998, DIABETOLOGIA, V41, pA182
[3]   Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2 [J].
Brubaker, PL ;
Crivici, A ;
Izzo, N ;
Ehrlich, P ;
Tsai, CH ;
Drucker, DJ .
ENDOCRINOLOGY, 1997, 138 (11) :4837-4843
[4]   HUMAN COLON PRODUCES FULLY PROCESSED GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE [J].
DEACON, CF ;
JOHNSEN, AH ;
HOLST, JJ .
FEBS LETTERS, 1995, 372 (2-3) :269-272
[5]   Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig [J].
Deacon, CF ;
Hughes, TE ;
Holst, JJ .
DIABETES, 1998, 47 (05) :764-769
[6]   BOTH SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED GLUCAGON-LIKE PEPTIDE-I ARE RAPIDLY DEGRADED FROM THE NH2-TERMINUS IN TYPE-II DIABETIC-PATIENTS AND IN HEALTHY-SUBJECTS [J].
DEACON, CF ;
NAUCK, MA ;
TOFTNIELSEN, M ;
PRIDAL, L ;
WILLMS, B ;
HOLST, JJ .
DIABETES, 1995, 44 (09) :1126-1131
[7]   DEGRADATION OF GLUCAGON-LIKE PEPTIDE-1 BY HUMAN PLASMA IN-VITRO YIELDS AN N-TERMINALLY TRUNCATED PEPTIDE THAT IS A MAJOR ENDOGENOUS METABOLITE IN-VIVO [J].
DEACON, CF ;
JOHNSEN, AH ;
HOLST, JJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :952-957
[8]   Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig [J].
Deacon, CF ;
Pridal, L ;
Klarskov, L ;
Olesen, M ;
Holst, JJ .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1996, 271 (03) :E458-E464
[9]   Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV [J].
Drucker, DJ ;
Shi, Q ;
Crivici, A ;
SumnerSmith, M ;
Tavares, W ;
Hill, M ;
DeForest, L ;
Cooper, S ;
Brubaker, PL .
NATURE BIOTECHNOLOGY, 1997, 15 (07) :673-677
[10]   A NOVEL FORM OF DIPEPTIDYLPEPTIDASE-IV FOUND IN HUMAN SERUM - ISOLATION, CHARACTERIZATION, AND COMPARISON WITH T-LYMPHOCYTE MEMBRANE DIPEPTIDYLPEPTIDASE-IV (CD26) [J].
DUKECOHAN, JS ;
MORIMOTO, C ;
ROCKER, JA ;
SCHLOSSMAN, SF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (23) :14107-14114